Indietro

Selezionare la regione

Azienda

Richiedi un consulto sulle cellule staminali

Per saperne di più

I nostri
trapianti

Elenco degli utilizzi delle cellule staminali approvati dai laboratori del gruppo FamiCord:

Immagine
Elenco degli utilizzi delle cellule staminali approvati dai laboratori del gruppo FamiCord:
Nr. Fonte Tipo di fonte Diagnosi Settore medico Anno di applicazione Terapia Paese Età del destinatario
201 Bone Marrow Allogeneic Fanconi Anemia hematology 2026 Standard Therapy USA 7
202 Bone Marrow Allogeneic Other Combined Immunodeficiency hematology 2026 Standard Therapy USA 8 months
203 Bone Marrow Allogeneic Acute Myelogenous Leukemia hematology 2026 Standard Therapy Spain 14
204 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia hematology 2026 Standard Therapy Poland 3
205 Bone Marrow Allogeneic Myelodysplastic Syndrome hematology 2026 Standard Therapy Italy 1
206 Bone Marrow Allogeneic Severe Aplastic Anemia hematology 2026 Standard Therapy USA 76
207 Bone Marrow Allogeneic Acute Myelogenous Leukemia hematology 2026 Standard Therapy Germany 38
208 Bone Marrow Allogeneic Sickle cell disease hematology 2026 Standard Therapy Netherlands 17
209 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard therapy Colombia 1
210 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2026 Standard therapy Poland 15
211 Bone Marrow Allogeneic Anaplastic Large Cell Lymphoma Hematology 2026 Standard therapy Slovakia 5
212 Bone Marrow Allogeneic MPS-I: Hurler Syndrome Hematology 2026 Standard therapy Russian Federation 10 months
213 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2026 Standard therapy Poland 8
214 Apheresis Autologous Multiple Myeloma Hematology 2026 Standard Therapy Germany 61
215 Apheresis Autologous Plasmablastic Lymphoma Hematology 2026 Standard Therapy Germany 69
216 Apheresis Autologous Multiple Myeloma Hematology 2026 Standard Therapy Germany 60
217 Apheresis Autologous Multiple Myeloma Hematology 2026 Standard Therapy Portugal 54
218 Apheresis Autologous Multiple Myeloma Hematology 2026 Standard Therapy Portugal 67
219 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy France 68
220 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Canada 69
221 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy Italy 66
222 Apheresis Allogeneic Fanconi Anemia Hematology 2026 Standard Therapy Germany 4
223 Apheresis Allogeneic Leukemia T-PLL Hematology 2026 Standard Therapy Norway 64
224 Apheresis Allogeneic T-cell NHL Non-Hodgkin Lymphoma Hematology 2026 Standard Therapy Germany 46
225 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy Germany 60
226 Apheresis Allogeneic MM, Myeloma Multiplex Hematology 2026 Standard Therapy Poland 48
227 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Norway 29
228 Apheresis Allogeneic Myelofibrosis Myeloid Metaplasia Hematology 2026 Standard Therapy USA 27
229 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Austria 34
230 Apheresis Allogeneic Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes(MDS) Hematology 2026 Standard Therapy Poland 55
231 Apheresis Allogeneic Thalassemia Major Hematology 2026 Standard Therapy Turkey 11
232 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Norway 59
233 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy USA 75
234 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Hungary 62
235 Apheresis Allogeneic 2nd Myelodysplastic Syndrome Hematology 2026 Standard Therapy Netherlands 67
236 Apheresis Allogeneic Acute Myelomonocytic Leukemia (AMML) Hematology 2026 Standard Therapy Ukraine 44
237 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Portugal 59
238 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2026 Standard Therapy Germany 54
239 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy France 67
240 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2026 Standard Therapy Spain 47
241 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2026 Standard Therapy Hungary 42
242 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Hungary 67
243 Apheresis Allogeneic Prolymphocytic Leukemia Hematology 2026 Standard Therapy USA 66
244 Apheresis Allogeneic Other Myelofibrosis/Myelosclerosis Hematology 2026 Standard Therapy USA 59
245 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2026 Standard Therapy USA 52
246 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Australia 57
247 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Australia 56
248 Apheresis Allogeneic Chronic Myelomonocytic Leukemia (CMML) Hematology 2026 Standard Therapy Germany 56
249 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Ukraine 37
250 Apheresis Allogeneic Sickle Cell Anemia Hematology 2026 Standard Therapy Germany 10
251 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Germany 71
252 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Canada 69
253 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy France 51
254 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy USA 63
255 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy USA 65
256 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2026 Standard Therapy Sweden 68
257 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Czechia 67
258 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Spain 63
259 Apheresis Allogeneic Chronic Lymphocytic Leukemia Hematology 2026 Standard Therapy Australia 57
260 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy USA 51
261 Apheresis Allogeneic B-Cell Acute Lymphoblastic Leukemia (B-ALL) Hematology 2026 Standard Therapy Poland 46
262 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Germany 59
263 Apheresis Allogeneic Primary Myelofibrosis (PMF) Hematology 2026 Standard Therapy Poland 59
264 Apheresis Autologous T-cell Lymphoblastic Lymphoma Hematology 2026 Standard Therapy Germany 40
265 Apheresis Autologous Anaplastic Large-Cell Lymphoma Hematology 2026 Standard Therapy Germany 68
266 Apheresis Autologous Central Nervous System Lymphoma Hematology 2026 Standard Therapy Germany 51
267 Apheresis Autologous Multiple Myeloma Hematology 2026 Standard Therapy Germany 64
268 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2026 Standard Therapy Germany 58
269 Apheresis Autologous Multiple Myeloma Hematology 2026 Standard Therapy Germany 63
270 Apheresis Autologous T-Cell Lymphoma Hematology 2026 Standard Therapy Germany 68
271 Apheresis Autologous Multiple Myeloma Hematology 2026 Standard Therapy Germany 68
272 Apheresis Autologous Multiple Myeloma Hematology 2026 Standard Therapy Germany 65
273 Apheresis Allogeneic Chronic Myeloid Leukemia Hematology 2026 Standard Therapy United Kingdom 55
274 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy Poland 65
275 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy Austria 43
276 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2026 Standard Therapy USA 60
277 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2026 Standard Therapy Poland 58
278 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2026 Standard Therapy Spain 66
279 Apheresis Allogeneic Myelodysplastic Syndrome IB2 Hematology 2026 Standard Therapy Germany 59
280 Apheresis Allogeneic Myelofibrosis Myeloid Metaplasia Hematology 2026 Standard Therapy USA 63
281 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy Israel 74
282 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy USA 67
283 Apheresis Allogeneic Serum Amyloid A (SAA) Hematology 2026 Standard Therapy United Kingdom 11
284 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy Germany 54
285 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy India 52
286 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy India 45
287 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Spain 62
288 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Netherlands 47
289 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Poland 58
290 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Lithuania 63
291 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy United Kingdom 56
292 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2026 Standard Therapy Germany 72
293 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy United Kingdom 30
294 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Germany 69
295 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy USA 70
296 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Ireland 73
297 Apheresis Allogeneic Other Leukemia, Specify, Chronic Neutrophilic Leukemia Hematology 2026 Standard Therapy USA 56
298 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2026 Standard Therapy USA 60
299 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy Spain 64
300 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Poland 66